JPMorgan analyst Milene Carvalho upgraded Braskem to Overweight from Neutral with a $5.50 price target. The firm cites improved market fundamentals, tighter supply, and strengthened governance post the company's restructuring for the upgrade. Braskem is positioned for a stronger 2026 as global market challenges and logistics constraints in the Middle East have tightened petrochemical supply and supported margin improvement, the analyst tells investors in a research note.
